The average reduced rate of tumor volume was significantly lower in TTLL6 overexpressed group than that in GFP overexpressed control group, and it was significantly higher in TTLL6 silenced group than that in shRNA control group (Figure 5B). The gene discussed is TTLL6; the disease is neoplasm.